5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Frontline Therapy in CLL: Obinutuzumab + Ibrutinib, Ibrutinib vs. Chemoimmunotherapy
Comments 0
Login to view comments.
Click here to Login